Sa1880 DOSE ESCALATION OF SUBCUTANEOUS VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS: A POST HOC ANALYSIS OF THE VISIBLE TRIAL DATA
Sandborn, William J., Wolf, Douglas C., D'Haens, Geert R., Jansson, Johan P., Chen, Jingjing, Uddin, Sharif M., Candela, Ninfa, Lasch, Karen, Kisfalvi, KrisztinaVolume:
158
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(20)31839-4
Date:
May, 2020
File:
PDF, 732 KB
2020